Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6702010 | 0.74 | F10 (0.72) | F10KLK1 | |
| SCHEMBL6803352 | 0.74 | F10 (0.72) | F10KLK1 | |
| SCHEMBL6804050 | 0.72 | F10 (0.72) | F10KLK1 | |
| SCHEMBL6803341 | 0.72 | F10 (0.68) | F10KLK1 | |
| SCHEMBL6803345 | 0.72 | F10 (0.68) | F10KLK1 | |
| SCHEMBL6804056 | 0.70 | F10 (0.69) | F10KLK1 | |
| SCHEMBL6730422 | 0.69 | F10 (0.74) | F10KLK1 | |
| SCHEMBL6730695 | 0.69 | F10 (0.76) | F10KLK1 | |
| SCHEMBL5196283 | 0.69 | F10 (0.71) | F10KLK1 | |
| SCHEMBL5090977 | 0.69 | F10 (0.68) | F10KLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040082786-A1 | Piperazine based inhibitors of factor xa | MILENNIUM PHARMACEUTICALS, INC. | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082786-A1 | Piperazine based inhibitors of factor xa | TFPI, F11, F12 | F10 11/4885KLK1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.